Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
Laboratory of Stem Cell and Tissue Engineering, Orthopedic Research Institute, Department of Orthopedics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
J Pathol. 2024 Jun;263(2):203-216. doi: 10.1002/path.6275. Epub 2024 Mar 29.
Urothelial damage and barrier dysfunction emerge as the foremost mechanisms in Hunner-type interstitial cystitis/bladder pain syndrome (HIC). Although treatments aimed at urothelial regeneration and repair have been employed, their therapeutic effectiveness remains limited due to the inadequate understanding of specific cell types involved in damage and the lack of specific molecular targets within these mechanisms. Therefore, we harnessed single-cell RNA sequencing to elucidate the heterogeneity and developmental trajectory of urothelial cells within HIC bladders. Through reclustering, we identified eight distinct clusters of urothelial cells. There was a significant reduction in UPK3A umbrella cells and a simultaneous increase in progenitor-like pluripotent cells (PPCs) within the HIC bladder. Pseudotime analysis of the urothelial cells in the HIC bladder revealed that cells faced challenges in differentiating into UPK3A umbrella cells, while PPCs exhibited substantial proliferation to compensate for the loss of UPK3A umbrella cells. The urothelium in HIC remains unrepaired, despite the substantial proliferation of PPCs. Thus, we propose that inhibiting the pivotal signaling pathways responsible for the injury to UPK3A umbrella cells is paramount for restoring the urothelial barrier and alleviating lower urinary tract symptoms in HIC patients. Subsequently, we identified key molecular pathways (TLR3 and NR2F6) associated with the injury of UPK3A umbrella cells in HIC urothelium. Finally, we conducted in vitro and in vivo experiments to confirm the potential of the TLR3-NR2F6 axis as a promising therapeutic target for HIC. These findings hold the potential to inhibit urothelial injury, providing promising clues for early diagnosis and functional bladder self-repair strategies for HIC patients. © 2024 The Pathological Society of Great Britain and Ireland.
逼尿肌上皮损伤和屏障功能障碍是 Hunner 型间质性膀胱炎/膀胱疼痛综合征(HIC)的主要机制。虽然已经采用了旨在促进尿路上皮再生和修复的治疗方法,但由于对参与损伤的特定细胞类型的认识不足以及这些机制中缺乏特定的分子靶点,其治疗效果仍然有限。因此,我们利用单细胞 RNA 测序来阐明 HIC 膀胱中尿路上皮细胞的异质性和发育轨迹。通过重新聚类,我们鉴定出 8 个不同的尿路上皮细胞簇。在 HIC 膀胱中,UPK3A 伞细胞显著减少,同时祖细胞样多能细胞(PPC)增加。对 HIC 膀胱中尿路上皮细胞的拟时分析表明,细胞在分化为 UPK3A 伞细胞方面面临挑战,而 PPC 大量增殖以补偿 UPK3A 伞细胞的丢失。尽管 PPC 大量增殖,HIC 的尿路上皮仍未修复。因此,我们提出抑制负责 UPK3A 伞细胞损伤的关键信号通路对于恢复尿路上皮屏障和缓解 HIC 患者的下尿路症状至关重要。随后,我们鉴定出与 HIC 尿路上皮 UPK3A 伞细胞损伤相关的关键分子途径(TLR3 和 NR2F6)。最后,我们进行了体外和体内实验,以证实 TLR3-NR2F6 轴作为 HIC 有前途的治疗靶点的潜力。这些发现有可能抑制尿路上皮损伤,为 HIC 患者的早期诊断和功能性膀胱自我修复策略提供有希望的线索。©2024 英国和爱尔兰病理学会。